User:Mr. Ibrahem/Vismodegib

Vismodegib, sold under the brand name Erivedge, is a medication used to treat basal-cell cancer (BCC). Specifically it is used in those in who the cancer has spread or has recurred and cannot be treated by other methods. It is taken by mouth.

Common side effects include hair loss, tiredness, nausea, and muscle spasms. Use during pregnancy may harm the baby. Effective birth control is recommended for both men and women. It is a hedgehog pathway inhibitor.

Vismodegib was approved for medical use in the United States in 2012 and Europe in 2013. In the United States it costs about 12,300 USD per month as of 2021 and is only available through specialty pharmacies. In the United Kingdom this amount costs the NHS about £6,300.